China sprints ahead in CRISPR therapy race.
Science (New York, N.Y.), 358(6359): 20-21 PMID 28983027 DOI 10.1126/science.358.6359.20
Abstract
This article has no abstract in PubMed.
Your browser does not allow saving data (e.g. private mode): bookmarks will be lost when the tab closes.
Science (New York, N.Y.), 358(6359): 20-21 PMID 28983027 DOI 10.1126/science.358.6359.20
This article has no abstract in PubMed.